Consensus on Current Injectable Treatment Strategies in the Asian Face
- PDF / 999,959 Bytes
- 13 Pages / 595.276 x 790.866 pts Page_size
- 25 Downloads / 202 Views
ORIGINAL ARTICLE
AESTHETIC
Consensus on Current Injectable Treatment Strategies in the Asian Face Woffles T. L. Wu1 • Steven Liew2 • Henry H. Chan3 • Wilson W. S. Ho4 • Nantapat Supapannachart5 • Hong-Ki Lee6 • Adri Prasetyo7 • Jonathan Nevin Yu8 John D. Rogers9 • Asian Facial Aesthetics Expert Consensus Group
•
Received: 16 June 2015 / Accepted: 8 January 2016 / Published online: 18 February 2016 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Background The desire for and use of nonsurgical injectable esthetic facial treatments are increasing in Asia. The structural and anatomical features specific to the Asian face, and differences from Western populations in facial aging, necessitate unique esthetic treatment strategies, but published recommendations and clinical evidence for injectable treatments in Asians are scarce. Method The Asian Facial Aesthetics Expert Consensus Group met to discuss current practices and consensus opinions on the cosmetic use of botulinum toxin and hyaluronic acid (HA) fillers, alone and in combination, for facial This article is being reprinted for ISAPS 50th Anniversary Special Issue. On behalf of the Asian Facial Aesthetics Expert Consensus Group. The members of the Asian Facial Aesthetics Expert Consensus Group are given in Appendix. & Woffles T. L. Wu [email protected] 1
Camden Medical Centre, Woffles Wu Aesthetic Surgery and Laser Centre, 1 Orchard Boulevard, Suite #09-02, Singapore 249615, Singapore
2
Shape Clinic, Sydney, Australia
3
Department of Medicine, University of Hong Kong, Pokfulam, Hong Kong
4
The Specialists: Lasers, Aesthetic and Plastic Surgery Central, Pokfulam, Hong Kong
5
Department of Dermatology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
6
Image Plastic Surgery Clinic, Seoul, Korea
7
REJUVA Clinic, Surabaya, Indonesia
8
JY Dermatology and Aesthetic Center, Manila, Philippines
9
Regional Medical Affairs, Allergan Asia Pacific, Singapore, Singapore
applications in Southeastern and Eastern Asians. Consensus opinions and statements on treatment aims and current practice were developed following discussions regarding pre-meeting and meeting survey outcomes, peer-reviewed literature, and the experts’ clinical experience. Results The indications and patterns of use of injectable treatments vary among patients of different ages, and among Asian countries. The combination use of botulinum toxin and fillers increases as patients age. Treatment aims in Asians and current practice regarding the use of botulinum toxin and HA fillers in the upper, middle, and lower face of patients aged 18 to[55 years are presented. Conclusions In younger Asian patients, addressing proportion and structural features and deficiencies are important to achieve desired esthetic outcomes. In older patients, maintaining facial structure and volume and addressing lines and folds are essential to reduce the appearance of aging. This paper provides guidance on treatment strategies to address the complex esthetic
Data Loading...
